BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14704397)

  • 1. Disclosure and disinterest.
    Kennedy D
    Science; 2004 Jan; 303(5654):15. PubMed ID: 14704397
    [No Abstract]   [Full Text] [Related]  

  • 2. Science and regulation. A White House mandate for more peer review.
    Kaiser J
    Science; 2003 Sep; 301(5638):1307. PubMed ID: 12958338
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory policy. White House softens disputed peer-review plan.
    Kaiser J
    Science; 2004 Apr; 304(5670):496-7. PubMed ID: 15105462
    [No Abstract]   [Full Text] [Related]  

  • 4. Questions about disclosure.
    Henry CJ
    Science; 2004 Jun; 304(5676):1447-9; author reply 1447-9. PubMed ID: 15178785
    [No Abstract]   [Full Text] [Related]  

  • 5. Science and government. Disclosure in regulatory science.
    Michaels D; Wagner W
    Science; 2003 Dec; 302(5653):2073. PubMed ID: 14684806
    [No Abstract]   [Full Text] [Related]  

  • 6. Editors and conflict of interest.
    Baggs JG; Schmitt MH
    Res Nurs Health; 2003 Apr; 26(2):87-9. PubMed ID: 12652605
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus.
    Bazell R
    New Repub; 1992 Nov; 207(20):21-2. PubMed ID: 11659543
    [No Abstract]   [Full Text] [Related]  

  • 8. Peer review and federal regulations.
    Steinbrook R
    N Engl J Med; 2004 Jan; 350(2):103-4. PubMed ID: 14711908
    [No Abstract]   [Full Text] [Related]  

  • 9. Full disclosure of financial interests in biomedical publications--a reminder.
    Bailey BJ
    Laryngoscope; 2002 Feb; 112(2):211-2. PubMed ID: 11889370
    [No Abstract]   [Full Text] [Related]  

  • 10. Grants management. NSF survey of applicants finds a system teetering on the brink.
    Mervis J
    Science; 2007 Aug; 317(5840):880-1. PubMed ID: 17702914
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 12. Declaration of financial interests.
    Nat Cell Biol; 2001 Oct; 3(10):E219-20. PubMed ID: 11584279
    [No Abstract]   [Full Text] [Related]  

  • 13. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
    Jordan KA
    Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
    [No Abstract]   [Full Text] [Related]  

  • 14. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
    Clamon JB
    Iowa Law Rev; 2003 Oct; 89(1):235-71. PubMed ID: 15732180
    [No Abstract]   [Full Text] [Related]  

  • 15. Praise, for a change.
    Kennedy D
    Science; 2004 May; 304(5674):1077. PubMed ID: 15155914
    [No Abstract]   [Full Text] [Related]  

  • 16. National Institutes of Health enacts final ethics regulations.
    Ness AC
    J Biolaw Bus; 2006; 9(1):50-1. PubMed ID: 17111527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors, industry, and review articles.
    DeMaria AN
    J Am Coll Cardiol; 2004 Mar; 43(6):1130-1. PubMed ID: 15028380
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
    Anraku A; Jin YP; Trope GE; Buys YM
    Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scholarly publishing. U.S. eases the squeeze on 'sanctioned' authors.
    Bhattacharjee Y
    Science; 2004 Apr; 304(5668):187. PubMed ID: 15073341
    [No Abstract]   [Full Text] [Related]  

  • 20. Financial conflicts of interest in biomedical human subject research.
    Goldstein N
    J Biolaw Bus; 2006; 9(1):26-37. PubMed ID: 17111525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.